Initial results from an international, investigator-initiated, open label phase III trial were presented at EULAR 2012, the Annual Congress of the European League Against Rheumatism. Data indicate that haematopoietic stem cell transplantation (HSCT) results in better long term survival than...
A three-drug treatment for the blood cancer multiple myeloma provided rapid, deep and potentially durable responses, researchers report online in Blood, the Journal of the American Society of Hematology, and at the American Society of Clinical Oncology's Annual Meeting in Chicago, IL, USA. The...
A new medication proved effective in slowing the spread of metastatic prostate cancer, while helping to maintain the quality of life, in patients with advanced disease. The phase 3 study was unblinded midway, allowing patients receiving the placebo to instead take the drug because of the...
The introduction of daily bathing with disposable, germ-killing cloths resulted in a sustained, significant decrease in methicillin-resistant Staphylococcus aureus (MRSA) incidence at a Canadian geriatric facility, according to a poster presented at the 39th Annual Educational Conference and...
Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen-deprivation therapy (also known as hormone therapy) than on intermittent therapy, according to a seventeen-year study led by SWOG, a cancer research cooperative group funded by the National Cancer...
Cancer patients with annual household incomes below $50,000 were less likely to participate in clinical trials than patients with annual incomes of $50,000 or higher, and were more likely to be concerned about how to pay for clinical trial participation. This is the conclusion of a large study...
Inflammatory breast cancer is a very aggressive type of cancer associated with early metastasis and poor survival rates, and the prognosis is even worse for patients with tumors expressing the ErbB2 receptor. The ErbB2-inhibiting drug lapatinib can slow the spread of cancer cells in individuals...
More than one-fifth of people who have received referrals to test for cancer-causing genes say they will only undergo testing if their insurance covers the cost - just as more insurers are instituting cost-sharing for medical services like genetic testing, according to new findings from Fox...
New research found that moderate exercise does not improve lipoprotein concentrations in obese patients with non alcoholic fatty liver disease (NAFLD). Results published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, report that moderate...
In a world first, scientists have grown new, healthy heart muscle cells using skin cells from heart failure patients. Writing about their work in a paper published online this week in the European Heart Journal, the Israel-based team explain how the new heart muscle cells are capable of...
Treatment of early stage prostate cancer can also result in improved quality of life for a subgroup of men who suffer from lower urinary tract symptoms (LUTS), according to an abstract of a Beth Israel Deaconess Medical Center-led study presented to the American Urological Association. LUTS...
Nordic walking enables heart failure patients to exercise more intensely than walking without poles. The research was presented at the Heart Failure Congress 2012, 19-22 May, in Belgrade, Serbia. The Congress is the main annual meeting of the Heart Failure Association of the European Society of...
ACE2, a molecule that has been shown to prevent damage in the heart, is now proving to be protective of the major organs that are often damaged in diabetic patients. Gavin Oudit, a researcher with the Faculty of Medicine & Dentistry, and his colleagues at the University of Florida, found that...
NAFLD (non-alcoholic fatty liver disease) is the most common type of liver disease in the developed world, affecting up to one-third of the US population. NAFLD is often associated with obesity and other parameters of the so-called "metabolic syndrome," which is a major risk factor for the...
Hospitals that perform expensive, invasive cardiovascular procedures on a disproportionate number of patients are more costly for all heart failure patients, including those treated with noninvasive methods, according to a new Yale study. Most heart failure patients are cared for without the use...
Acute ischemic stroke patients taking the blood thinner warfarin can be treated safely with the clot-busting drug tissue plasminogen activator (tPA), according to research presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2012. "Although it's...
Heart attack patients in North Carolina who were rushed directly to hospitals equipped to do percutaneous coronary intervention (PCI) received treatment significantly faster than patients first taken to hospitals unequipped to perform PCI and then later transferred for treatment, according to...
Having several medical conditions is not more predominant in those who are older; a new study published Online First in The Lancet reveals that the majority of patients who suffer from two or more conditions are actually below the age of 65 years. A radical health system overhaul is required so...
Lyrica® (pregabalin) is now available in a new strawberry-flavored oral solution form in the UK, in order to benefit patients who have difficulty in taking medication in capsule form or for those with dysphagia (swallowing difficulty). Pregabalin is licensed to treat peripheral and central...
A new analysis may help doctors identify breast cancer patients who will benefit from treatment with the immune suppressant drug everolimus, say French researchers at the 4th IMPAKT Breast Cancer Conference in Brussels, Belgium. Everolimus is currently used as an immunosuppressant to prevent...